Softgel Capsules: Global Markets

Report Highlights

The global market for softgel capsules was valued at $7.4 billion in 2023. The market is expected to grow from $7.9 billion in 2024 to $11.5 billion by 2029, at a compound annual growth rate, or CAGR, of 7.7% from 2024 through 2029.

Report Includes

• 73 data tables and 31 additional tables
• Analyses of global market trends for softgel capsules, with market revenue data from 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
• Estimates of the market size and revenue prospects of the global market, along with a market share analysis by product type, application, end user and region/country
• Analysis of the market dynamics, industry trends, competitive landscape and regulatory scenario
• A Porter’s Five Forces model, and global supply chain and companies’ SWOT analyses
• Patent activity and key patent grants/publications
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, ESG score analysis, and the ESG practices of leading companies
• Analysis of the industry structure, including companies’ market shares, strategic alliances, M&A activity and a venture funding outlook
• Profiles of market leaders, including Thermo Fisher Scientific Inc., Catalent Inc., Aenova Group, Sirio Pharma Co. Ltd., and CAPTEK Softgel International Inc.

Report Scope

The global softgel capsules market and all major global softgel capsules companies are identified in this report. The total softgel capsules market is broken out globally and by geographic region. All major product types and applications are covered in detail. The current report will provide detailed exposure to softgel capsules.

This report will provide detailed information on the softgel capsules market. This report analyzes the market trends of softgel capsules with data from 2023, estimates from 2024, projections of compound annual growth rates through 2029 (forecast period of 2024 through 2029), and regional markets of softgel capsules. This report will highlight softgel capsules’ current and future market potential and give a detailed analysis of the competitive environment. The report will cover regulatory scenarios, drivers, restraints, and opportunities. The report also covers market projections for 2029 and the market share for key market players.

The report also details market shares for softgel capsules based on product type, application, end user, and geography. The market is segmented into gelatin and vegetarian capsules based on product type. The market is segmented based on its nutritional, pharmaceutical and cosmeceutical applications. Based on end-users, the market is segmented into pharmaceutical and nutraceutical companies, contract manufacturing companies and others.

The market has been segmented into significant geographical regions: North America, Europe, Asia-Pacific, and the Rest of the World. The regional segment will cover a detailed analysis of the market in major countries such as the U.S., Germany, the U.K., France, Japan, China, and India. For market estimates, data will be provided for 2023 as the base year, with forecasts for 2024 through 2029.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Consulting Editor’s Credentials

Dr. Marianna Tcherpakov has more than 10 years of experience as a bench scientist specializing in the areas of biochemistry, cell biology, assay development, antibody and drug manufacturing. She has authored several scientific publications in peer review journals. In the last 10 years, Marianna worked as a business development professional in CRO/CDMO industry. She is familiar with pharmaceutical and biotech landscape, trends and potential future developments in industry.